Design, synthesis and evaluation of novel 5,6,7-trimethoxyflavone-6-chlorotacrine hybrids as potential multifunctional agents for the treatment of Alzheimer's disease.

[1]  C. To,et al.  Potential therapeutic effects of baicalein, baicalin, and wogonin in ocular disorders. , 2014, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[2]  F. J. Luque,et al.  Tetrahydrobenzo[h][1,6]naphthyridine-6-chlorotacrine hybrids as a new family of anti-Alzheimer agents targeting β-amyloid, tau, and cholinesterase pathologies. , 2014, European journal of medicinal chemistry.

[3]  Y. Ohizumi,et al.  Anti-dementia Activity of Nobiletin, a Citrus Flavonoid: A Review of Animal Studies , 2014, Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology.

[4]  Ying Guo,et al.  Design, synthesis, and biological evaluation of (e)-3,4-dihydroxystyryl aralkyl sulfones and sulfoxides as novel multifunctional neuroprotective agents. , 2014, Journal of medicinal chemistry.

[5]  Sanghyun Lee,et al.  Rational design of a structural framework with potential use to develop chemical reagents that target and modulate multiple facets of Alzheimer's disease. , 2014, Journal of the American Chemical Society.

[6]  Neng Jiang,et al.  Design, synthesis and evaluation of novel tacrine-rhein hybrids as multifunctional agents for the treatment of Alzheimer's disease. , 2014, Organic & biomolecular chemistry.

[7]  Xingshu Li,et al.  Novel tacrine-ebselen hybrids with improved cholinesterase inhibitory, hydrogen peroxide and peroxynitrite scavenging activity. , 2013, Bioorganic & medicinal chemistry letters.

[8]  Sai-Sai Xie,et al.  Multifunctional tacrine-flavonoid hybrids with cholinergic, β-amyloid-reducing, and metal chelating properties for the treatment of Alzheimer's disease. , 2013, European journal of medicinal chemistry.

[9]  Rangappa S. Keri,et al.  Design, synthesis and neuroprotective evaluation of novel tacrine-benzothiazole hybrids as multi-targeted compounds against Alzheimer's disease. , 2013, Bioorganic & medicinal chemistry.

[10]  Hai-bin Luo,et al.  Design, synthesis, and evaluation of multitarget-directed resveratrol derivatives for the treatment of Alzheimer's disease. , 2013, Journal of medicinal chemistry.

[11]  S. Garneau‐Tsodikova,et al.  Investigation of the role of linker moieties in bifunctional tacrine hybrids. , 2013, Bioorganic & medicinal chemistry.

[12]  Xiaobing Wang,et al.  Design, synthesis and evaluation of flavonoid derivatives as potential multifunctional acetylcholinesterase inhibitors against Alzheimer's disease. , 2013, Bioorganic & medicinal chemistry letters.

[13]  W. Thies,et al.  2013 Alzheimer's disease facts and figures , 2013, Alzheimer's & Dementia.

[14]  I. Ginsburg,et al.  Carbamate derivatives of indolines as cholinesterase inhibitors and antioxidants for the treatment of Alzheimer's disease. , 2012, Journal of medicinal chemistry.

[15]  Paul Edison,et al.  Drug repositioning for Alzheimer's disease , 2012, Nature Reviews Drug Discovery.

[16]  Xingshu Li,et al.  Multitarget-directed benzylideneindanone derivatives: anti-β-amyloid (Aβ) aggregation, antioxidant, metal chelation, and monoamine oxidase B (MAO-B) inhibition properties against Alzheimer's disease. , 2012, Journal of medicinal chemistry.

[17]  Shu Liu,et al.  Design, synthesis and pharmacological evaluation of novel tacrine-caffeic acid hybrids as multi-targeted compounds against Alzheimer's disease. , 2012, Bioorganic & medicinal chemistry letters.

[18]  Filippo Caraci,et al.  New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugs. , 2012, British journal of clinical pharmacology.

[19]  Jörg Rademann,et al.  New tacrine-4-oxo-4H-chromene hybrids as multifunctional agents for the treatment of Alzheimer's disease, with cholinergic, antioxidant, and β-amyloid-reducing properties. , 2012, Journal of medicinal chemistry.

[20]  Z. Zuo,et al.  Pharmacological effects and pharmacokinetics properties of Radix Scutellariae and its bioactive flavones. , 2011, Biopharmaceutics & drug disposition.

[21]  Ding Li,et al.  Design, synthesis and evaluation of novel tacrine-multialkoxybenzene hybrids as dual inhibitors for cholinesterases and amyloid beta aggregation. , 2011, Bioorganic & medicinal chemistry.

[22]  F. J. Luque,et al.  Pyrano[3,2-c]quinoline-6-chlorotacrine hybrids as a novel family of acetylcholinesterase- and beta-amyloid-directed anti-Alzheimer compounds. , 2009, Journal of medicinal chemistry.

[23]  Richard Morphy,et al.  Designing multiple ligands - medicinal chemistry strategies and challenges. , 2009, Current pharmaceutical design.

[24]  G. Perry,et al.  Alzheimer disease and the role of free radicals in the pathogenesis of the disease. , 2008, CNS & neurological disorders drug targets.

[25]  H. Otsuka,et al.  Antiviral activity of 5,6,7-trimethoxyflavone and its potentiation of the antiherpes activity of acyclovir. , 1997, The Journal of antimicrobial chemotherapy.